Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subspecialties Glaucoma

Visual fields and ocular surface - what is important for my glaucoma patients?

View on Demand

The webinar, organised and funded by Santen, provides an overview on the latest data on the relationship between ocular surface disease and topical antiglaucoma therapy and the impact of visual field loss in patients’ daily lives.

Learning Objectives of Webinar

  1. Ocular surface disease is more prevalent with patients treated with preserved mediations.
  2. Preservatives BAK and Polyquad have a high impact on ocular surface health.
  3. Visual field loss can have a significant impact on patient’s quality of life.

Enjoy our FREE content!

Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!

Login if you already created an account

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine
Register

Or Login as a Guest or via Social Media

Newsletter

Send me the latest from The Ophthalmologist.

Sign up now

Related Articles

Subspecialties Glaucoma

Looking Back, Moving Forward

| I. Paul Singh

Subspecialties Glaucoma

A Glimpse Over the Horizon

| Jeffrey O'Callaghan

Subspecialties Glaucoma

Singing the Blues

| Kevin Waltz

Most Popular

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register